Gluomni M1

Gluomni M1 by EMK Omni Pharma is a prescription-based Metformin Hydrochloride SR and Glimepiride Tablets IP formulation used for doctor-supervised type 2 diabetes management, blood sugar control, and long-term glycaemic support. Each uncoated bilayer tablet contains Metformin Hydrochloride IP 500 mg in sustained release form and Glimepiride IP 1 mg. Gluomni M1 is commonly prescribed by healthcare professionals for patients who require support in managing high blood glucose levels, insulin resistance, glucose imbalance, and type 2 diabetes care. The sustained release Metformin formulation helps support prolonged blood sugar control, while Glimepiride supports physician-guided diabetes treatment as part of a complete diabetes care plan.

Gluomni M1 may be prescribed by doctors for patients who require support in managing type 2 diabetes, high blood sugar levels, insulin resistance, glucose imbalance, and long-term glycaemic control. It may be used as part of a physician-guided diabetes care plan that includes medication, diet management, regular blood sugar monitoring, exercise, and lifestyle correction. Gluomni M1 by EMK Omni Pharma is suitable for doctor-supervised treatment where sustained blood glucose control, diabetes management, and metabolic health support are required. Patients should not self-medicate, change the dosage, stop the medicine, crush the tablet, or combine it with other diabetes medicines without consulting their doctor.